CAS: 136468-36-5 - Foropafant
Fórmula:C28H40N4S
InChI:InChI=1/C28H40N4S/c1-19(2)23-14-24(20(3)4)27(25(15-23)21(5)6)26-18-33-28(30-26)32(13-12-31(7)8)17-22-10-9-11-29-16-22/h9-11,14-16,18-21H,12-13,17H2,1-8H3
- Sinónimos:
- Sr 27417
- N,N-dimethyl-N'-(pyridin-3-ylmethyl)-N'-{4-[2,4,6-tri(propan-2-yl)phenyl]-1,3-thiazol-2-yl}ethane-1,2-diamine
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
1,2-Ethanediamine, N1,N1-dimethyl-N2-(3-pyridinylmethyl)-N2-[4-[2,4,6-tris(1-methylethyl)phenyl]-2-thiazolyl]- REF: IN-DA0011WHCAS: 136468-36-5 | 98% | A consultar | Mié 13 Nov 24 | |
Foropafant REF: 3D-LFA46836CAS: 136468-36-5 | Min. 95% | A consultar | Vie 27 Dic 24 | |
Foropafant REF: TM-T15338CAS: 136468-36-5 | 99.13% | 54,00 €~807,00 € | Mié 15 Ene 25 |
1,2-Ethanediamine, N1,N1-dimethyl-N2-(3-pyridinylmethyl)-N2-[4-[2,4,6-tris(1-methylethyl)phenyl]-2-thiazolyl]-
CAS:136468-36-5
Fórmula:
C28H40N4S
Pureza:
98%
Forma y color:
Solid
Peso molecular:
464.7090
Ref: IN-DA0011WH
1mg | 145,00 € | ||
5mg | 231,00 € | ||
10mg | 546,00 € | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 13 de Noviembre de 2024
Foropafant
CAS:136468-36-5
Foropafant is a small molecule that inhibits transcription by binding to the polymerase-binding site of …
Fórmula:
C28H40N4S
Pureza:
Min. 95%
Peso molecular:
464.72 g/mol
Ref: 3D-LFA46836
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 27 de Diciembre de 2024
Foropafant
CAS:136468-36-5
Foropafant (SR27417) is a highly potent and selective platelet-activating factor (PAF) receptor antagonist (Ki: 57 …
Fórmula:
C28H40N4S
Pureza:
99.13%
Forma y color:
Solid
Peso molecular:
464.71
Ref: TM-T15338
1mg | 54,00 € | ||
5mg | 113,00 € | ||
10mg | 174,00 € | ||
25mg | 296,00 € | ||
50mg | 426,00 € | ||
100mg | 599,00 € | ||
200mg | 807,00 € | ||
1mL*10mM (DMSO) | 130,00 € |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025